Quinn Opportunity Partners LLC Purchases Shares of 81,588 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Quinn Opportunity Partners LLC purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 81,588 shares of the pharmacy operator's stock, valued at approximately $761,000.

A number of other large investors have also recently made changes to their positions in the stock. Norges Bank purchased a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $58,241,000. Invesco Ltd. boosted its position in Walgreens Boots Alliance by 8.8% during the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock worth $303,902,000 after purchasing an additional 2,631,332 shares in the last quarter. Vanguard Group Inc. grew its holdings in Walgreens Boots Alliance by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after purchasing an additional 2,279,495 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of Walgreens Boots Alliance by 19.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock valued at $122,737,000 after buying an additional 2,185,950 shares in the last quarter. Finally, Amundi lifted its position in shares of Walgreens Boots Alliance by 70.3% during the 4th quarter. Amundi now owns 4,455,720 shares of the pharmacy operator's stock valued at $41,082,000 after buying an additional 1,839,045 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Up 0.4 %

Shares of NASDAQ:WBA traded up $0.05 during mid-day trading on Thursday, hitting $10.85. The stock had a trading volume of 3,862,840 shares, compared to its average volume of 23,979,814. The company has a market cap of $9.38 billion, a PE ratio of -1.06, a P/E/G ratio of 1.31 and a beta of 0.67. The company's 50 day moving average is $10.80 and its 200-day moving average is $10.10. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.10. The firm had revenue of $38.59 billion during the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.20 EPS. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have issued reports on WBA shares. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. StockNews.com began coverage on Walgreens Boots Alliance in a report on Friday, April 11th. They issued a "hold" rating on the stock. Royal Bank of Canada boosted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research report on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their target price for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Truist Financial dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.